Max Healthcare Institute Limited (MAXHEALTH) — Board Meeting | 30 January 2025

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Max Healthcare Institute's board approved unaudited Q3 FY2025 results (ended Dec 31, 2024) showing revenue of ₹87.22 crores, up 32% YoY, with net profit of ₹12.45 crores. The company finalized the acquisition of Jaypee Healthcare for ₹62.47 crores, recognizing ₹56.10 crores as goodwill, and approved a ₹500 crore term loan from Axis Bank for a new Gurugram hospital. Strategic expansions include bed capacity increases to 400+ in Zirakpur and a 500+ bed facility in Thane, alongside a ₹200 crore unsecured loan to Eqova Healthcare for an East Delhi hospital project.

📄 View Original Announcement (PDF)

About Max Healthcare Institute Limited (MAXHEALTH)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹1,02,200.33 Cr P/E: 101.2

View full MAXHEALTH stock details →

📡 Get AI alerts when MAXHEALTH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MAXHEALTH — Free

📊 More MAXHEALTH filings

See all MAXHEALTH filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MAXHEALTH files new disclosures

Track MAXHEALTH filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MAXHEALTH — Free

Free account · 2 AI queries/day